Skip to main content
Erschienen in:

07.03.2024 | Leber | Originalien

Leber und Schwangerschaft

verfasst von: Prof. Andrea De Gottardi, MD PhD, Dr. med. Nadine Stanek

Erschienen in: Schweizer Gastroenterologie | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Zusammenfassung

Bei Patientinnen ohne Vorerkrankungen der Leber können während der Schwangerschaft Störungen der Leberfunktion relativ häufig vorkommen. Diese sind zum Teil spezifisch (Hyperemesis gravidarum, intrahepatische Cholestase der Schwangerschaft, akute Fettlebererkrankung der Schwangerschaft) oder unspezifisch (virale Hepatitiden, alkoholische Hepatitis, Autoimmun- oder metabolische Erkrankungen der Leber). Es gibt ausserdem besondere Krankheitsbilder, wie zum Beispiel Leberadenome oder das Budd-Chiari-Syndrom, in denen eine spezielle Betreuung notwendig ist. Eine Schwangerschaft kann auch bei Frauen mit einer fortgeschrittenen Lebererkrankung auftreten. In diesem Zusammenhang spielen Kontrazeption, Planung sowie eine adäquate Überwachung eine zentrale Rolle. In diesem Artikel werden diagnostische und therapeutische Aspekte dieser Situationen diskutiert und mit praxisrelevanten Hinweisen ergänzt.
Literatur
1.
Zurück zum Zitat Bell H, Raknerud N, Falch JA, Haug E (1995) Inappropriately low levels of gonadotrophins in amenorrhoeic women with alcoholic and non-alcoholic cirrhosis. Eur J Endocrinol 132(4):444–449CrossRefPubMed Bell H, Raknerud N, Falch JA, Haug E (1995) Inappropriately low levels of gonadotrophins in amenorrhoeic women with alcoholic and non-alcoholic cirrhosis. Eur J Endocrinol 132(4):444–449CrossRefPubMed
2.
Zurück zum Zitat Jabiry-Zieniewicz Z, Bobrowska K, Kaminski P, Wielgos M, Zieniewicz K, Krawczyk M (2007) Low-dose hormonal contraception after liver transplantation. Transplant Proc 39(5):1530–1532CrossRefPubMed Jabiry-Zieniewicz Z, Bobrowska K, Kaminski P, Wielgos M, Zieniewicz K, Krawczyk M (2007) Low-dose hormonal contraception after liver transplantation. Transplant Proc 39(5):1530–1532CrossRefPubMed
3.
Zurück zum Zitat McKay DB, Josephson MA, Armenti VT, August P, Coscia LA, Davis CL et al (2005) Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant 5(7):1592–1599CrossRefPubMed McKay DB, Josephson MA, Armenti VT, August P, Coscia LA, Davis CL et al (2005) Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant 5(7):1592–1599CrossRefPubMed
4.
Zurück zum Zitat Ko CW, Beresford SAA, Schulte SJ, Matsumoto AM, Lee SP (2005) Incidence, natural history, and risk factors for biliary sludge and stones during pregnancy. Hepatology 41(2):359–365CrossRefPubMed Ko CW, Beresford SAA, Schulte SJ, Matsumoto AM, Lee SP (2005) Incidence, natural history, and risk factors for biliary sludge and stones during pregnancy. Hepatology 41(2):359–365CrossRefPubMed
5.
Zurück zum Zitat Bredaki FE, Sciorio C, Wright A, Wright D, Nicolaides KH (2015) Serum alpha-fetoprotein in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol 46(1):34–41CrossRefPubMed Bredaki FE, Sciorio C, Wright A, Wright D, Nicolaides KH (2015) Serum alpha-fetoprotein in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol 46(1):34–41CrossRefPubMed
6.
Zurück zum Zitat Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB et al (2019) Screening for hepatitis B virus infection in pregnant women: US preventive services task force reaffirmation recommendation statement. JAMA 322(4):349–354CrossRefPubMed Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB et al (2019) Screening for hepatitis B virus infection in pregnant women: US preventive services task force reaffirmation recommendation statement. JAMA 322(4):349–354CrossRefPubMed
7.
Zurück zum Zitat Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y et al (2016) Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med 374(24):2324–2334CrossRefPubMed Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y et al (2016) Tenofovir to prevent hepatitis B transmission in mothers with high viral load. N Engl J Med 374(24):2324–2334CrossRefPubMed
8.
Zurück zum Zitat Strandberg-Larsen K, Poulsen G, Bech BH, Chatzi L, Cordier S, Dale MTG et al (2017) Association of light-to-moderate alcohol drinking in pregnancy with preterm birth and birth weight: elucidating bias by pooling data from nine European cohorts. Eur J Epidemiol 32(9):751–764CrossRefPubMed Strandberg-Larsen K, Poulsen G, Bech BH, Chatzi L, Cordier S, Dale MTG et al (2017) Association of light-to-moderate alcohol drinking in pregnancy with preterm birth and birth weight: elucidating bias by pooling data from nine European cohorts. Eur J Epidemiol 32(9):751–764CrossRefPubMed
9.
Zurück zum Zitat Towers CV, Katz E, Weitz B, Visconti K (2020) Use of naltrexone in treating opioid use disorder in pregnancy. Am J Obstet Gynecol 222(1):83.e1–83.e8CrossRefPubMed Towers CV, Katz E, Weitz B, Visconti K (2020) Use of naltrexone in treating opioid use disorder in pregnancy. Am J Obstet Gynecol 222(1):83.e1–83.e8CrossRefPubMed
10.
Zurück zum Zitat Edmondson HA, Henderson B, Benton B (1976) Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med 294(9):470–472CrossRefPubMed Edmondson HA, Henderson B, Benton B (1976) Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med 294(9):470–472CrossRefPubMed
11.
Zurück zum Zitat Sarkar M, Brady CW, Fleckenstein J, Forde KA, Khungar V, Molleston JP et al (2021) Reproductive health and liver disease: practice guidance by the American association for the study of liver diseases. Hepatology 73(1):318–365CrossRefPubMed Sarkar M, Brady CW, Fleckenstein J, Forde KA, Khungar V, Molleston JP et al (2021) Reproductive health and liver disease: practice guidance by the American association for the study of liver diseases. Hepatology 73(1):318–365CrossRefPubMed
12.
Zurück zum Zitat Holmes VA, Wallace JMW (2005) Haemostasis in normal pregnancy: a balancing act? Biochem Soc Trans 33(Pt 2):428–432CrossRefPubMed Holmes VA, Wallace JMW (2005) Haemostasis in normal pregnancy: a balancing act? Biochem Soc Trans 33(Pt 2):428–432CrossRefPubMed
13.
Zurück zum Zitat Ibiebele I, Schnitzler M, Nippita T, Ford JB (2017) Outcomes of gallstone disease during pregnancy: a population-based data linkage study. Paediatr Perinat Epidemiol 31(6):522–530CrossRefPubMed Ibiebele I, Schnitzler M, Nippita T, Ford JB (2017) Outcomes of gallstone disease during pregnancy: a population-based data linkage study. Paediatr Perinat Epidemiol 31(6):522–530CrossRefPubMed
14.
Zurück zum Zitat Li M, Bu Q, Gong W, Li H, Wang L, Li S et al (2020) Hepatitis E virus infection and its associated adverse feto-maternal outcomes among pregnant women in Qinhuangdao, China. J Matern Fetal Neonatal Med 33(21):3647–3651CrossRefPubMed Li M, Bu Q, Gong W, Li H, Wang L, Li S et al (2020) Hepatitis E virus infection and its associated adverse feto-maternal outcomes among pregnant women in Qinhuangdao, China. J Matern Fetal Neonatal Med 33(21):3647–3651CrossRefPubMed
15.
Zurück zum Zitat Bergløv A, Hallager S, Weis N (2019) Hepatitis E during pregnancy: maternal and foetal case-fatality rates and adverse outcomes—A systematic review. J Viral Hepat 26(11):1240–1248CrossRefPubMed Bergløv A, Hallager S, Weis N (2019) Hepatitis E during pregnancy: maternal and foetal case-fatality rates and adverse outcomes—A systematic review. J Viral Hepat 26(11):1240–1248CrossRefPubMed
16.
Zurück zum Zitat Westbrook RH, Yeoman AD, O’Grady JG, Harrison PM, Devlin J, Heneghan MA (2011) Model for end-stage liver disease score predicts outcome in cirrhotic patients during pregnancy. Clin Gastroenterol Hepatol 9(8):694–699CrossRefPubMed Westbrook RH, Yeoman AD, O’Grady JG, Harrison PM, Devlin J, Heneghan MA (2011) Model for end-stage liver disease score predicts outcome in cirrhotic patients during pregnancy. Clin Gastroenterol Hepatol 9(8):694–699CrossRefPubMed
17.
Zurück zum Zitat Shaheen AAM, Myers RP (2010) The outcomes of pregnancy in patients with cirrhosis: a population-based study. Liver Int 30(2):275–283CrossRefPubMed Shaheen AAM, Myers RP (2010) The outcomes of pregnancy in patients with cirrhosis: a population-based study. Liver Int 30(2):275–283CrossRefPubMed
18.
19.
Zurück zum Zitat Bicocca MJ, Sperling JD, Chauhan SP (2018) Intrahepatic cholestasis of pregnancy: Review of six national and regional guidelines. Eur J Obstet Gynecol Reprod Biol 231:180–187CrossRefPubMed Bicocca MJ, Sperling JD, Chauhan SP (2018) Intrahepatic cholestasis of pregnancy: Review of six national and regional guidelines. Eur J Obstet Gynecol Reprod Biol 231:180–187CrossRefPubMed
20.
Zurück zum Zitat Wikström Shemer EA, Stephansson O, Thuresson M, Thorsell M, Ludvigsson JF, Marschall HU (2015) Intrahepatic cholestasis of pregnancy and cancer, immune-mediated and cardiovascular diseases: A population-based cohort study. J Hepatol 63(2):456–461CrossRefPubMed Wikström Shemer EA, Stephansson O, Thuresson M, Thorsell M, Ludvigsson JF, Marschall HU (2015) Intrahepatic cholestasis of pregnancy and cancer, immune-mediated and cardiovascular diseases: A population-based cohort study. J Hepatol 63(2):456–461CrossRefPubMed
21.
Zurück zum Zitat Erez O, Romero R, Jung E, Chaemsaithong P, Bosco M, Suksai M et al (2022) Preeclampsia and eclampsia: the conceptual evolution of a syndrome. Am J Obstet Gynecol 226(2S):S786–803CrossRefPubMedPubMedCentral Erez O, Romero R, Jung E, Chaemsaithong P, Bosco M, Suksai M et al (2022) Preeclampsia and eclampsia: the conceptual evolution of a syndrome. Am J Obstet Gynecol 226(2S):S786–803CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Williamson C, Nana M, Poon L, Kupcinskas L, Painter R, Taliani G et al (2023) EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy. J Hepatol 79(3):768–828CrossRef Williamson C, Nana M, Poon L, Kupcinskas L, Painter R, Taliani G et al (2023) EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy. J Hepatol 79(3):768–828CrossRef
23.
Zurück zum Zitat Browning MF, Levy HL, Wilkins-Haug LE, Larson C, Shih VE (2006) Fetal fatty acid oxidation defects and maternal liver disease in pregnancy. Obstet Gynecol 107(1):115–120CrossRefPubMed Browning MF, Levy HL, Wilkins-Haug LE, Larson C, Shih VE (2006) Fetal fatty acid oxidation defects and maternal liver disease in pregnancy. Obstet Gynecol 107(1):115–120CrossRefPubMed
Metadaten
Titel
Leber und Schwangerschaft
verfasst von
Prof. Andrea De Gottardi, MD PhD
Dr. med. Nadine Stanek
Publikationsdatum
07.03.2024
Verlag
Springer Vienna
Erschienen in
Schweizer Gastroenterologie / Ausgabe 1/2024
Print ISSN: 2662-7140
Elektronische ISSN: 2662-7159
DOI
https://doi.org/10.1007/s43472-024-00123-y

Weitere Artikel der Ausgabe 1/2024

Schweizer Gastroenterologie 1/2024 Zur Ausgabe

Editorial

Editorial

Éditorial

Éditorial

Editoriale

Editoriale